Morgan Stanley analyst Carlos De Alba maintains Cleveland-Cliffs (NYSE:CLF) with a Equal-Weight and lowers the price target from $24 to $16.
Nyxoah Proposes Public Offering Of Ordinary Shares; No Size Or Amount Disclosed
Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the
